Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Publisher Correction: Carbohydrate fatty acid monosulphate: oil-in-water adjuvant enhances SARS-CoV-2 RBD nanoparticle-induced immunogenicity and protection in mice.

Autor: Nanishi E; Precision Vaccines Program, Boston Children's Hospital, Boston, MA, USA.; Department of Pediatrics, Harvard Medical School, Boston, MA, USA., Borriello F; Precision Vaccines Program, Boston Children's Hospital, Boston, MA, USA.; Department of Pediatrics, Harvard Medical School, Boston, MA, USA.; Division of Immunology, Boston Children's Hospital, Boston, MA, USA.; Generate Biomedicines, Cambridge, MA, USA., Seo HS; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., O'Meara TR; Precision Vaccines Program, Boston Children's Hospital, Boston, MA, USA., McGrath ME; Department of Microbiology and Immunology, Center for Pathogen Research, University of Maryland School of Medicine, Baltimore, MD, USA., Saito Y; Precision Vaccines Program, Boston Children's Hospital, Boston, MA, USA., Chen J; Research Computing Group, Boston Children's Hospital, Boston, MA, USA., Diray-Arce J; Precision Vaccines Program, Boston Children's Hospital, Boston, MA, USA.; Department of Pediatrics, Harvard Medical School, Boston, MA, USA., Song K; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA., Xu AZ; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA., Barman S; Precision Vaccines Program, Boston Children's Hospital, Boston, MA, USA.; Department of Pediatrics, Harvard Medical School, Boston, MA, USA., Menon M; Precision Vaccines Program, Boston Children's Hospital, Boston, MA, USA., Dong D; Precision Vaccines Program, Boston Children's Hospital, Boston, MA, USA., Caradonna TM; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA., Feldman J; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA., Hauser BM; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA., Schmidt AG; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA.; Department of Microbiology, Harvard Medical School, Boston, MA, USA., Baden LR; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA., Ernst RK; Department of Microbial Pathogenesis, University of Maryland School of Dentistry, Baltimore, MD, USA., Dillen C; Department of Microbiology and Immunology, Center for Pathogen Research, University of Maryland School of Medicine, Baltimore, MD, USA., Yu J; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Chang A; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Hilgers L; LiteVax B.V, Oss, The Netherlands., Platenburg PP; LiteVax B.V, Oss, The Netherlands., Dhe-Paganon S; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Barouch DH; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Ozonoff A; Precision Vaccines Program, Boston Children's Hospital, Boston, MA, USA.; Department of Pediatrics, Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT & Harvard, Cambridge, MA, USA., Zanoni I; Department of Pediatrics, Harvard Medical School, Boston, MA, USA.; Division of Immunology, Boston Children's Hospital, Boston, MA, USA., Frieman MB; Department of Microbiology and Immunology, Center for Pathogen Research, University of Maryland School of Medicine, Baltimore, MD, USA., Dowling DJ; Precision Vaccines Program, Boston Children's Hospital, Boston, MA, USA.; Department of Pediatrics, Harvard Medical School, Boston, MA, USA., Levy O; Precision Vaccines Program, Boston Children's Hospital, Boston, MA, USA. ofer.levy@childrens.harvard.edu.; Department of Pediatrics, Harvard Medical School, Boston, MA, USA. ofer.levy@childrens.harvard.edu.; Broad Institute of MIT & Harvard, Cambridge, MA, USA. ofer.levy@childrens.harvard.edu.

Publikováno v: NPJ vaccines [NPJ Vaccines] 2023 Mar 03; Vol. 8 (1), pp. 30. Date of Electronic Publication: 2023 Mar 03.